Lecture 5 - Genetics and Treatment Flashcards

1
Q

decitabine is a DNA ______ agent used to help increase the levels of ____ in sickle cell anemia

A

hypomethylating;

HbF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what disorder is ivacftor/kalydec used to treat?

A

CF

helps improve FEV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

____ ____ can be given to patietns with urea cycle disease to divert ammonia away

A

sodium benzoate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

a ______ _____ can be given to patients with Duchenne’s to cause skipping of a stop codon in exon 51

A

antisense oligonucleotide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

with viral gene therapy, a ______ sequence is required in addition to the therapeutic sequence

A

packaging

ie it has genes to make viral envelope

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

retrovrius vectors:
does gene get passed to progeny of cell?

requires ____ cells. risk of _____ mutagenesis

A

yes;
dividing;

insertional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

adenovirus vectors:

does gene get passed to progeny of cell?

_____ ie may stimulate destruction of transgene containing cells

A

no (so transient expression);

immunogenic;

low risk of insertional mutagenesis, easy to purify and concentrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adenosine Deaminase Deficiency:
inheritance =
causes accumulation of ____ –> _____ toxicity and SCID

A

autosomal recessive;
dATP;
lymphocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ADA deficiency:
can treat with pegylated _____;
ie a ____cellular replacement for a ___cellular enzyme

A

ADA;

extracellular, intracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

X-linked SCID:
due to defective ____;

can use ex vivo gene therapy with ____ + cells–> risk of developing ____

A

IL-2 Receptor (gamma chain);

CD34+

leukemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

factor 8 deficiency can be treated by injecting a vector into ____, which is a good target because the cells rarely divide

A

muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ornithine Transcarbamylase (OTC) deficiency:
inheritance =
excess _____ _____ is converted to ____ ____

A

X-linked recessive;

carbamoyl phosphate, orotic acid;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

OTC deficiency:

findings include increased _____ in blood and urine, decreased ____, and symptoms of hyper______

A

orotic acid;
BUN;
hyperammonemia

no anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

jesse gelsinger:

had OTC, was given gene therapy contained in a _____ vector. died from strong ____ ____

A

adenovirus;

immune response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

method to increase aggressive chemo:

introduce _____ gene into stem cells, which repairs DNA damage, treat patient with _____, which causes DNA damage (in cancer cells)

A

MGMT;

BCNU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2 ways to interfere with gene expression by affecting DNA

A

decoys, triplex formation

17
Q

a _____ is RNA with enzymatic activity that can target RNA for degradation

A

ribozyme

18
Q

miRNA:
coding or noncoding RNA?

act pretranscriptionally or post transcriptionally?

target the ____ region of specific mRNAs

A

noncoding;

post transcriptionally;

3’ untranslated region

19
Q

miRNA:

binds to the ______ _____ complex –> repression of _____ or mRNA degradation

A

RNA-induced silencing complex (RiSC);

translation

20
Q

siRNA:
enters cell by ____ _____.;
induces ____transcriptional gene silencing by binding complementary sequences

A

chemical transcfection;

post

21
Q

shRNA:

is expressed in a cell from a ____, resulting in ____ similar to miRNA

A

vector;
hairpins

ie shRNA = miRNA except expressed as a vector

22
Q

clinical trials:
phase ____ compares the new treatment to the current standard of care.

phase ____ assess safety and toxicity in healthy volunteers

phase ____ assess treatment efficacy and optimal dosing

A

3, 1, 2

23
Q

2 places you can get adult stem cells from

A
bone marrow;
peripheral blood (via apheresis)
24
Q

what location of the pre-implantation embryo can you get stem cells from?

A

inner cell mass

25
Q

with somatic cell nuclear transfer/therapeutic cloning, an enucleated ______ receives the nucleus of an ____ cell

A

oocyte (egg);

adult

26
Q

autologous cells are from ______;

allogenic cells are from ______

A

self (ie your own cells);

someone else (of same species)